PMPRB Hearing Panel issues decision in Procysbi case
A Patented Medicine Prices Review Board (PMPRB) Hearing Panel issued its decision relating to the medicine Procysbi, manufactured and marketed in Canada by Horizon Pharma.
Read the original at the source: https://www.canada.ca/en/patented-medicine-prices-review/news/2022/09/pmprb-hearing-panel-issues-decision-in-procysbi-case.html
Officially imported this from Patented Medicine Prices Review Board’s own source. If you work there, claiming the profile and verifying the domain lets you choose to show the full text here.
Provenance
- Organization
- Patented Medicine Prices Review Board — imported from official source
- Official source
- https://api.io.canada.ca/io-server/gc/news/en/v2?dept=patentedmedicinepricesreviewboard&sort=publishedDate&orderBy=desc&publishedDate%3E=2021-07-23&pick=50&format=atom&atomtitle=Patented%20Medicine%20Prices%20Review%20Board ATOM
- Imported
- October 03, 2026 20:43
- Versions
- 1 recorded
- Identity
https://www.canada.ca/en/patented-medicine-prices-review/news/2022/09/pmprb-hearing-pan...